Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study

@inproceedings{Chang2011CancerRA,
  title={Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study},
  author={C Chang and Sengwee Toh and Jou-Wei Lin and Shu-Ting Chen and Chuei-Wen Kuo and Lee-Ming Chuang and M W Lai},
  booktitle={PloS one},
  year={2011}
}
BACKGROUND Preclinical and observational studies raise the concern about the safety of insulin glargine in terms of cancer initiation and promotion. This study is designed to examine cancer incidence associated with use of insulin glargine vs. intermediate/long-acting human insulin (HI). METHODOLOGY A retrospective cohort study using the Taiwan National Health Insurance claims database was conducted to identify adult patients with type 2 diabetes mellitus and without a history of cancer who… CONTINUE READING
32 Citations
20 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

for Drug Statistics Methodology

  • WHO Collaborating Centr
  • Defined daily dose: definition and general…
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…